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Abstract.  Exposure to UV radiation is known to be a 
causative factor in the induction of skin cancers and other 
sun-related disorders. Most acute responses of humans to 
UV exposure occur as a result of UVB (280 to 315 nm) 
exposures, as these wavelengths are highly sensitive in 
creating a human biological response. However, this does 
not mean that UVA radiation has no impact on human UV 
exposures and health. UVA can cause erythema in human 
skin, yet, the exposures required to create such a response 
is much larger than UVB radiation. UVA radiation 
penetrates much deeper into human skin tissue than UVB, 
resulting in impacts that are not as acute, taking many 
years to manifest. Past research has shown that UVA (315 
to 400 nm) plays a significant role in human skin 
carcinogenesis. Studies have also shown that UVA plays an 
important role in skin damage, immune suppression, DNA 
damage, photoageing and wrinkling. Researchers at the 
University of Southern Queensland have developed a 
personal UV dosimeter that can quantitatively assess long 
term solar UVA exposures. The chemical polyphenylene 
oxide, cast in thin film form and which is responsive to 
both the UVA and UVB part of the spectrum was used and 
filtered with mylar. This combined system responded to 
the UVA wavelengths only and underwent a change in 
optical absorbance as a result of UVA exposure. 
Preliminary results indicate that this UVA dosimeter 
saturates reasonably slowly when exposed to sunlight and 
can measure exposures of more than 20 MJm-2 of solar 
UVA radiation with an uncertainty level of no more than ± 
5%. 
Introduction 
Over exposure to UV radiation can cause serious damage 
to the human eyes and skin. Skin cancer is considered the 
most common malignant neoplasm in Australia and the 
USA (Kricker and Armstrong, 1996; Glanz and Mayer, 
2005; NCI, 2007). Over 1,600 Australians die from skin 
cancer each year and a further 380,000 Australians are 
treated for skin cancer each year (NCCI, 2003; AIHW, 
2004; AIHW, 2005). Estimates put direct health care costs 
of all types of skin cancer in Australia in the region of 
$734.9 million per year, with the indirect costs in the form 
of sick leave and foregone earnings in the region of $1.395 
billion per year (Armstrong, 1995). As a result, it is 
essential to decrease any exposure to damaging solar UV 
radiation that the population experiences. This requires 
constructive methods to understand the solar UV radiation 
environment that humans live in. Quantification of the 
individual level of solar UV radiation exposure requires 
personal dosimetry due to changes in the position of 
people compared to the radiation source.  
Commonly used UV chemical dosimeters are 
polysulphone and phenothiazine. Phenothiazine has been 
used for measuring UVA wavelengths in various 
environments (Parisi et al, 2005). However, phenothiazine 
only has the capability to record a cumulative exposure 
over a small time period, usually three to four hours. This 
small dynamic range greatly reduces the amount of time 
over which a UVA exposure can be measured in the field. 
Therefore, a chemical dosimeter that can be employed that 
is capable of measuring large amounts of UV radiation 
over a long time period would be very useful. Research 
conducted by Davis et al (1976) showed that Poly 
(2,6-dimethyl-1, 4-phenylene oxide) (PPO) film could be 
employed to measure high levels of UV exposure. Further 
research (Davis et al, 1981; Berre and Lala, 1989; Lester et 
al, 2003) found PPO to be ideal for this purpose as it 
would allow for unattended measurements to be made at 
various locations over extensive amounts of time. PPO 
dosimeters have been utilised in the measurement of global 
UV exposures, however, they have not been used to 
measure long term solar UVA exposures. The aim of this 
paper was to extend the previous research that has 
employed PPO dosimeters for the measurement of solar 
UV exposures to investigate the suitability of PPO for the 
long term measurement of solar UVA exposures. 
Methodology 
PPO film of approximately 40 µm thickness was attached 
with adhesive tape to a plastic holder. The holders for the 
dosimeters were 3 x 3 cm in size and fabricated from thin 
polyvinylchloride with an aperture of approximately 1.2 x 
1.6 cm. A UV/visible spectrophotometer (model 1601, 
Shimadzu Co., Kyoto, Japan) was used to measure the pre 
and post exposure absorbance of the dosimeter. PPO is 
responsive to both the UVA and UVB part of the solar 
spectrum, therefore the UVB wavelengths were filtered by 
placing mylar on top of the PPO film. For each dosimeter, 
the change in optical absorbance (ΔA330) due to UV 
exposure was measured at 320nm (with mylar removed) at 
four different sites over the dosimeter in order to minimise 
any errors due to any possible minor variations in the PPO 
film over the size of the dosimeter. The post exposure 
absorbance was measured at a standardized time following 
exposure to minimize any error associated with the post 
exposure ‘dark reaction’ of the PPO. 
 
The dosimeters were calibrated for UVA exposures by 
exposing a series of dosimeters on a horizontal plane, to 
relatively clear sky solar UV from approximately 0800 to 
1600 h Australian Eastern Standard Time (EST) for a total 
of 22 days. The SZA ranged from 30o to 75o. The PPO 
dosimeters were calibrated on a horizontal plane with a 
UVA meter (501 Biometer, Solar Light Co., Philadelphia, 
USA). The UVA meter was calibrated against a scanning 
spectroradiometer (Bentham Instruments, Ltd, Reading, 
UK). The spectroradiometer is based on a double grating 
monochromator, a UV sensitive detector and amplifier 
with software variable gain provided by a programmable 
high voltage power supply. The interior of the 
spectroradiometer enclosure is temperature stabilised to 
23.0 ± 0.5oC, using a Peltier heater/cooler unit. The input 
optics of the spectroradiometer are provided by a PTFE 
(polytetrafluoro ethylene) diffuser and connected by an 
optical fibre to the input slit of the monochromator. The 
spectroradiometer is programmed to start scanning at dawn, 
and thereafter every 5 minutes till dusk. The instrument is 
wavelength calibrated to the UV spectral lines of a 
mercury lamp and irradiance calibrated to a 150 Watt 
quartz tungsten halogen lamp with calibration traceable to 
the National Physical Laboratory, UK standard. 
 Results 
The calibration of the PPO dosimeters for solar UVA 
exposure is shown in Figure 1. The data points are the 
averages of the four ΔA’s measured for each dosimeter and 
the error bars on the x-axis values are the standard 
deviation of the four measurements. A trend curve was 
fitted to the calibration data with the form of: 
 
UVA = 1.2¯107(x0.51) J/m2   
 
The resulting R2 for the calibration was greater than 0.99. 
The spectral transmission of the mylar was measured 
pre-exposure and post-exposure to solar UV to test for any 
significant changes. The change in spectral transmission of 
the mylar is provided in Figure 2. The maximum change 
was approximately 13% at 333 nm. 
Figure 1.  Calibration curve for PPO UVA dosimeter. 
Figure 2. The spectral transmission of mylar pre and post 
exposure. 
 
For reproducibility tests, ten dosimeters were placed on a 
horizontal plane and exposed to solar UV. All dosimeters 
received the same exposure of solar UV producing a mean 
ΔA320 of 0.598 with a standard deviation of no more than 
±5%. This variation may be due minor variations over the 
surface of the sheet of PPO film from which the 
dosimeters were fabricated and the influence of dust 
particles that accumulated on the surface of the dosimeters 
during the exposure period. 
Discussion 
Preliminary results indicate that this UVA dosimeter 
saturates reasonably slowly when exposed to sunlight and 
can measure exposures of more than 20 MJm-2 of solar 
UVA radiation with an uncertainty level of no more than ± 
5%. The size and lightweight properties of the dosimeter 
means that it can be attached to the anatomical sites of life 
size manikins simulating humans in different environments 
in order to determine the UVA exposures to those sites. 
The usage of the dosimeter requires the calibration against 
a calibrated meter. The profile of the calibration curve will 
vary with the season and this can be overcome by 
calibrating the dosimeter in the season that it will be 
employed to measure the solar UVA exposures. 
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